Ptc Therapeutics (PTCT) Asset Utilization Ratio (2013 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Asset Utilization Ratio of 0.33 for Q2 2026, down 50.6% year-over-year from 0.67 in Q2 2025, and up 14.95% quarter-over-quarter from 0.29 in Q1 2026.
Ptc Therapeutics (PTCT) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Ptc Therapeutics' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.33 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio fell 50.6% year-over-year to 0.33; the TTM figure through Jun 2026 stood at 0.33 (down 50.6% YoY), while the FY2025 annual figure was 0.75, up 67.78% from the prior year.
- Asset Utilization Ratio for Q2 2026 stood at 0.33, up from 0.29 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.73 in Q1 2025, with the low at 0.29 in Q1 2026.
- The 5-year median for Asset Utilization Ratio is 0.45 (2023), against an average of 0.48.
- The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio jumped 78.63% in 2025, then sank 60.58% in 2026.
- Ptc Therapeutics' Asset Utilization Ratio stood at 0.43 in 2022, then jumped by 39.58% to 0.59 in 2023, then tumbled by 41.18% to 0.35 in 2024, then surged by 78.63% to 0.62 in 2025, then tumbled by 47.21% to 0.33 in 2026.
- Business Quant data shows PTCT's Asset Utilization Ratio at 0.33 in Q2 2026, 0.29 in Q1 2026, and 0.62 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.33 |
| Mar 31, 2026 | 0.29 |
| Dec 31, 2025 | 0.62 |
| Sep 30, 2025 | 0.67 |
| Jun 30, 2025 | 0.67 |
| Mar 31, 2025 | 0.73 |
| Dec 31, 2024 | 0.35 |
| Sep 30, 2024 | 0.38 |
| Jun 30, 2024 | 0.39 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.59 |
| Sep 30, 2023 | 0.61 |
| Jun 30, 2023 | 0.56 |
| Mar 31, 2023 | 0.46 |
| Dec 31, 2022 | 0.43 |
| Sep 30, 2022 | 0.41 |
| Jun 30, 2022 | 0.34 |
| Mar 31, 2022 | 0.30 |
| Dec 31, 2021 | 0.27 |
| Sep 30, 2021 | 0.24 |